US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Xcell Biosciences Inc.
Xcell Biosciences Expands AmplifyBio Collaboration with Unique Cell and Gene Therapy Manufacturing Capabilities
October 02, 2024
From
Xcell Biosciences Inc.
Via
Business Wire
Xcell Biosciences to Showcase Future of Cell Manufacturing at ISCT 2024
May 22, 2024
From
Xcell Biosciences Inc.
Via
Business Wire
AmplifyBio and Xcell Biosciences Announce Partnership to Manufacture Solid Tumor-Targeting TCR-T Cell Therapy
May 20, 2024
From
Xcell Biosciences Inc.
Via
Business Wire
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
April 01, 2024
From
Xcell Biosciences Inc.
Via
Business Wire
Tickers
LH
Xcell Biosciences Announces New Scientific and Business Advisory Board
March 27, 2024
From
Xcell Biosciences Inc.
Via
Business Wire
Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies
October 13, 2022
From
Xcell Biosciences Inc.
Via
Business Wire
Xcell Biosciences Appoints Shannon Eaker, Ph.D. as Chief Technology Officer
May 03, 2022
From
Xcell Biosciences Inc.
Via
Business Wire